# PPP1R1A

## Overview
The PPP1R1A gene encodes the protein phosphatase 1 regulatory inhibitor subunit 1A, a key regulatory protein that functions as an inhibitor of protein phosphatase 1 (PP1), a major serine/threonine phosphatase involved in numerous cellular processes. This protein, also known as inhibitor-1 (I-1), is characterized by its ability to modulate PP1 activity through phosphorylation, particularly at threonine-35, which significantly enhances its inhibitory capacity (Endo1996Multiple). The protein plays a critical role in various physiological contexts, including cardiac muscle contractility, glycogen metabolism, and insulin secretion, by maintaining the phosphorylation states of target proteins (Cataldo2021The; Casamayor2020Controlling). Additionally, PPP1R1A is involved in the regulation of blood pressure through its effects on the NaCl cotransporter in the kidney, highlighting its importance in cardiovascular and metabolic health (Grimm2023Dietary).

## Structure
The human protein phosphatase 1 regulatory inhibitor subunit 1A (PPP1R1A) is a protein that functions as an inhibitor of protein phosphatase 1 (PP1). The primary structure of PPP1R1A consists of 171 amino acids, with a high degree of sequence conservation in the N-terminal region, which includes a critical threonine residue phosphorylated by protein kinase A (PKA) (Endo1996Multiple). This phosphorylation is essential for the protein's inhibitory activity, as it induces a conformation that selectively recognizes and inhibits PP1 (Endo1996Multiple).

The secondary structure of PPP1R1A is largely disordered, as indicated by circular dichroism studies, and phosphorylation does not significantly alter this structure (Endo1996Multiple). The protein's functional domain is characterized by specific interactions with PP1, including binding to an 'acidic groove' and a 'hydrophobic groove' on the PP1 catalytic subunit (Endo1996Multiple).

Post-translational modifications, particularly the phosphorylation of threonine-35, are crucial for the protein's function. This modification enhances the inhibitory activity of PPP1R1A by 1000-fold (Endo1996Multiple). The protein does not exhibit a globular structure and is stable under various conditions, including heating and exposure to low pH (AITKEN1982Complete).

## Function
The PPP1R1A gene encodes the protein phosphatase 1 regulatory inhibitor subunit 1A, also known as inhibitor-1 (I-1), which plays a crucial role in regulating the activity of protein phosphatase 1 (PP1), a major serine/threonine phosphatase involved in various cellular processes. In its phosphorylated form, I-1 inhibits PP1, thereby modulating processes such as glycogen metabolism, cardiac muscle contractility, and cell division (Casamayor2020Controlling; Strath2009Identification).

In cardiac muscle cells, I-1 is involved in regulating cardiac contractility by maintaining the phosphorylation of phospholamban, which is essential for calcium cycling and heart function. This regulation is particularly beneficial in conditions such as heart failure (Casamayor2020Controlling). In β-cells, PPP1R1A is critical for glucose-stimulated insulin secretion (GSIS) and the amplification of this process through GLP-1 signaling. It influences mitochondrial function and energy metabolism, which are vital for insulin secretion and β-cell function (Cataldo2021The).

PPP1R1A also plays a role in the kidney, where it regulates the NaCl cotransporter (NCC) in response to dietary potassium. This regulation is part of a mechanism that affects blood pressure by modulating sodium excretion (Grimm2023Dietary).

## Clinical Significance
Alterations in the expression of the PPP1R1A gene have been linked to several clinical conditions, particularly in the context of type 2 diabetes and blood pressure regulation. In type 2 diabetes, reduced expression of PPP1R1A is associated with impaired β-cell function and dedifferentiation, contributing to the disease's progression. This reduction in expression is linked to the unresponsiveness of type 2 diabetic patients to GLP1R-based treatments, as PPP1R1A is crucial for the amplification of glucose-stimulated insulin secretion (GSIS) through incretin signaling (Cataldo2021The). The loss of PPP1R1A expression mimics β-cell dysfunction associated with chronic hyperglycemia, affecting the transcription of genes related to insulin secretion and metabolism (Cataldo2021The).

In the context of blood pressure regulation, PPP1R1A plays a significant role in the dephosphorylation of the kidney NaCl cotransporter (NCC) in response to dietary potassium. High potassium intake decreases PPP1R1A levels, leading to reduced NCC phosphorylation and subsequent blood pressure reduction. This mechanism suggests that PPP1R1A is involved in potassium-regulated blood pressure control, potentially linking it to conditions like salt-sensitive hypertension (Grimm2023Dietary). These findings highlight the potential of targeting PPP1R1A pathways in therapeutic strategies for type 2 diabetes and hypertension.

## Interactions
PPP1R1A, also known as protein phosphatase 1 regulatory inhibitor subunit 1A, interacts with protein phosphatase 1 (PP1) to modulate its activity. This interaction is primarily mediated through a phosphorylated threonine residue (Thr-35) and an RVXF motif, which binds to a hydrophobic groove in PP1C, the catalytic subunit of PP1. This binding is crucial for the inhibitory function of PPP1R1A on PP1C, affecting various cellular processes such as mitotic regulation and cardiac muscle contractility (Casamayor2020Controlling).

In the kidney, PPP1R1A is involved in the regulation of the NaCl cotransporter (NCC) through its interaction with PP1A. Under conditions of high dietary potassium, PPP1R1A is dephosphorylated, leading to increased PP1A activity and subsequent dephosphorylation of NCC. This interaction plays a significant role in blood pressure regulation by modulating sodium reabsorption in the distal convoluted tubule (Grimm2023Dietary).

In cardiac tissue, PPP1R1A, when phosphorylated, inhibits PP1C, thereby enhancing calcium cycling and contractile function. This interaction is beneficial in conditions such as heart failure and ischemia/reperfusion injury, where it helps maintain phospholamban phosphorylation and suppresses the endoplasmic reticulum stress response (Nicolaou2009Inducible).


## References


[1. (Nicolaou2009Inducible) Persoulla Nicolaou, Patricia Rodriguez, Xiaoping Ren, Xiaoyang Zhou, Jiang Qian, Sakthivel Sadayappan, Bryan Mitton, Anand Pathak, Jeffrey Robbins, Roger J. Hajjar, Keith Jones, and Evangelia G. Kranias. Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury. Circulation Research, 104(8):1012–1020, April 2009. URL: http://dx.doi.org/10.1161/circresaha.108.189811, doi:10.1161/circresaha.108.189811. This article has 90 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/circresaha.108.189811)

[2. (Cataldo2021The) Luis Rodrigo Cataldo, Neelanjan Vishnu, Tania Singh, Ludivine Bertonnier-Brouty, Sara Bsharat, Cheng Luan, Erik Renström, Rashmi B. Prasad, Malin Fex, Hindrik Mulder, and Isabella Artner. The mafa-target gene ppp1r1a regulates glp1r-mediated amplification of glucose-stimulated insulin secretion in β-cells. Metabolism, 118:154734, May 2021. URL: http://dx.doi.org/10.1016/j.metabol.2021.154734, doi:10.1016/j.metabol.2021.154734. This article has 22 citations.](https://doi.org/10.1016/j.metabol.2021.154734)

[3. (AITKEN1982Complete) Alastair AITKEN, Terry BILHAM, and Philip COHEN. Complete primary structure of protein phosphatase inhibitor‐1 from rabbit skeletal muscle. European Journal of Biochemistry, 126(2):235–246, August 1982. URL: http://dx.doi.org/10.1111/j.1432-1033.1982.tb06771.x, doi:10.1111/j.1432-1033.1982.tb06771.x. This article has 137 citations.](https://doi.org/10.1111/j.1432-1033.1982.tb06771.x)

[4. (Casamayor2020Controlling) Antonio Casamayor and Joaquín Ariño. Controlling Ser/Thr protein phosphatase PP1 activity and function through interaction with regulatory subunits, pages 231–288. Elsevier, 2020. URL: http://dx.doi.org/10.1016/bs.apcsb.2020.06.004, doi:10.1016/bs.apcsb.2020.06.004. This article has 24 citations.](https://doi.org/10.1016/bs.apcsb.2020.06.004)

[5. (Endo1996Multiple) Shogo Endo, Xiaozhen Zhou, John Connor, Bo Wang, and Shirish Shenolikar. Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor,. Biochemistry, 35(16):5220–5228, January 1996. URL: http://dx.doi.org/10.1021/bi952940f, doi:10.1021/bi952940f. This article has 127 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi952940f)

[6. (Strath2009Identification) Janet Strath, Lindsay J Georgopoulos, Paul Kellam, and G Eric Blair. Identification of genes differentially expressed as result of adenovirus type 5- and adenovirus type 12-transformation. BMC Genomics, February 2009. URL: http://dx.doi.org/10.1186/1471-2164-10-67, doi:10.1186/1471-2164-10-67. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2164-10-67)

[7. (Grimm2023Dietary) P. Richard Grimm, Anamaria Tatomir, Lena L. Rosenbaek, Bo Young Kim, Dimin Li, Eric J. Delpire, Robert A. Fenton, and Paul A. Welling. Dietary potassium stimulates ppp1ca-ppp1r1a dephosphorylation of kidney nacl cotransporter and reduces blood pressure. Journal of Clinical Investigation, November 2023. URL: http://dx.doi.org/10.1172/jci158498, doi:10.1172/jci158498. This article has 11 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci158498)